Alopecia Totalis and Universalis: Complete Hair Loss Explained

What Are Alopecia Totalis and Universalis?

Alopecia totalis (AT) and alopecia universalis (AU) sit on the severe end of the alopecia areata spectrum. In alopecia areata, the immune system attacks hair follicles, causing hair to fall out. Most people with alopecia areata have a few patches — but about 5-7% progress to AT (complete scalp hair loss) or AU (loss of all body hair, including eyebrows, eyelashes, nostril hair, and body hair).

It's important to understand that even in AT and AU, the hair follicles are still alive. They are in a dormant state caused by immune attack, not permanently scarred or destroyed. This means regrowth remains possible — sometimes years or even decades later — especially with newer treatments that target the specific immune pathways involved.

Who Gets It?

AT and AU can affect anyone at any age, but they are more common in people who:

Developed alopecia areata before puberty: Childhood onset is associated with more extensive and persistent disease.

Have other autoimmune conditions: People with thyroid disease, vitiligo, type 1 diabetes, or celiac disease are at higher risk.

Have a family history: Genetic factors play a significant role, with about 20% of patients having a family member with some form of alopecia areata.

AT and AU do not distinguish by sex — men and women are affected equally. The progression from patchy AA to AT/AU can happen rapidly (over weeks) or gradually over months to years.

Beyond Hair: Physical Effects

Losing all scalp or body hair goes beyond cosmetics. Without eyebrows and eyelashes, sweat and debris enter the eyes more easily, causing irritation. Loss of nostril hair reduces the nose's ability to filter dust and allergens. Loss of scalp hair affects temperature regulation — your head gets cold in winter and sunburns quickly in summer. You may find these practical challenges are manageable with simple adjustments: sunscreen or hats for the scalp, saline drops for dry eyes, and petroleum jelly or gentle ointments around the nose.

Treatment: The JAK Inhibitor Revolution

Before 2022, there were no FDA-approved treatments for alopecia areata of any severity. Options were limited to off-label use of steroids, immune-suppressing medications, and topical irritants — with generally disappointing results for AT/AU.

Baricitinib (Olumiant): The first FDA-approved oral treatment for severe alopecia areata in adults. In clinical trials, patients took 4mg daily. Among those with severe or total hair loss, about 35-40% achieved 80% or more scalp hair coverage after 36 weeks. Some people who had been completely bald for over 10 years regrew full heads of hair. Side effects include increased cholesterol, rare infections, and monitoring for blood clots.

Ritlecitinib (Litfulo): Approved for patients 12 and older, making it the first option for adolescents. About 23% achieved 80% or more coverage at 24 weeks, with ongoing improvement over time. Generally well-tolerated.

These medications work by blocking the JAK-STAT signaling pathway that drives the immune attack on follicles. They need to be taken continuously — if you stop, hair loss may recur. Your dermatologist will monitor you with regular blood tests.

Other treatments your doctor may discuss: High-dose pulse corticosteroids, methotrexate (an immune suppressant), and topical immunotherapy (DPCP). These have varying success rates and are sometimes used while waiting to start or in combination with JAK inhibitors.

Emotional and Psychological Impact

Living with AT or AU affects far more than appearance. Studies show significantly higher rates of anxiety and depression in people with severe alopecia. The loss of eyebrows and eyelashes can feel particularly distressing because they play a major role in facial expression and identity.

Professional mental health support is not a sign of weakness — it's a reasonable response to a real medical condition. You may find that many dermatology centers now integrate psychological support into their alopecia care teams. The National Alopecia Areata Foundation (NAAF) offers support groups, educational resources, and community connections.

Practical coping tools many patients find helpful: quality wigs (medical-grade wigs may be covered by insurance), permanent makeup for eyebrows, and magnetic or adhesive eyelashes. Some people choose to embrace baldness entirely — there is no wrong approach.

Frequently Asked Questions

Can someone who has been bald for years regrow hair?

Yes — the JAK inhibitor trials included patients who had been completely bald for over a decade, and some achieved significant regrowth. Because the follicles are dormant rather than destroyed, they can be "woken up" even after prolonged periods. However, individual results vary, and not everyone responds equally.

Are JAK inhibitors covered by insurance?

Coverage varies by plan. Many insurance companies now cover baricitinib and ritlecitinib for severe alopecia areata, though prior authorization is usually required. The manufacturer patient assistance programs can help with costs. Your dermatologist's office can help navigate the approval process.

Will my eyelashes and eyebrows grow back too?

Yes — JAK inhibitors can promote regrowth of eyebrows, eyelashes, and body hair, not just scalp hair. Clinical trials tracked these separately and showed improvement across all hair-bearing areas, though scalp hair typically responds first.

Is this the same as cancer-related hair loss?

No. Chemotherapy causes hair loss by attacking rapidly dividing cells (including hair cells). Alopecia areata/totalis/universalis is an autoimmune condition — the immune system attacks hair follicles specifically. The causes, treatments, and outlook are completely different.

References